Lv6
2696 积分 2021-09-12 加入
Venetoclax or Pirtobrutinib in Relapsed/Refractory Waldenström Macroglobulinemia: Clinical and Molecular Predictors and Sequencing Implications
5小时前
待确认
PD-1–based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma
8小时前
求助中
Emerging technologies for minimal residual disease detection in hematologic malignancies
8小时前
求助中
Patient-reported outcomes in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia receiving standard chemotherapy plus quizartinib or placebo (QuANTUM-First): a global, randomised, placebo-controlled, phase 3 trial
8小时前
求助中
Characterization of Hypogammaglobulinemia, Infection Incidence, and Mortality in Patients Receiving B-cell Maturation Antigen Chimeric Antigen Receptor (CAR) T-cell Therapy
9小时前
已完结
Measurable residual disease intervention in AML: a new therapeutic horizon
10小时前
求助中
Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis
18小时前
求助中
Trispecific Antibodies: From Challenges to Integration in Cancer Therapy
1天前
求助中
Very long‐term outcomes of chronic‐phase chronic myeloid leukaemia patients treated with imatinib: A 25‐year real‐world cohort study
1天前
已完结
Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality?
1天前
求助中
皖公网安备34019202002308
